Resources

Selected
  • Systematic reviews (SYSVAC)
Type of publications
Regions
Diseases
Vaccine topics
Target population
Publication date
2750 results found
2025 ∙ Tahrat, H. Munir, A. Marchetti, F.
Rotavirus vaccine coverage, completion, and compliance: A systematic literature review
Newborn Children Rotavirus Coverage
Rating:
Not applicable
2025 ∙ Chiavarini, M. Genga, A. Ricciotti, G. M. D'Errico, M. M. Barbadoro, P.
Safety, Immunogenicity, and Efficacy of Cytomegalovirus Vaccines: A Systematic Review of Randomized Controlled Trials
All age groups Cytomegalovirus Safety Efficacy/effectiveness
Rating:
Critically low
2025 ∙ Al-omoush, O. Khalil, L. Ramadan, A. Tarakhan, H. Alzoubi, A. Nabil, A. Hajali, M. Abdelazeem, B. Saleh, O.
Sarcoidosis and COVID-19 Vaccines: A Systematic Review of Case Reports and Case Series
All age groups COVID-19 Safety
Rating:
Critically low
2025 ∙ Sheng-Kai Ma, K. Shen, C. H. Chiang, M. H. Blumenthal, K. G. Chen, S. T.
Severe Cutaneous Adverse Reactions Following Vaccination: A Systematic Review and Meta-analysis
All age groups Safety
Rating:
Critically low
2025 ∙ Okoli, G. N. Soos, A. E. Etsell, K. Grossman Moon, A. Kimmel Supron, H. Grewal, A. Neilson, C. J. Richardson, C. Harper, D. M.
Socioeconomic and Health-Related Characteristics Associated with Initiation and Completion of Human Papillomavirus Vaccination among Males in the United States: An In-Depth Systematic Review and Meta-Analysis
Americas United States of America Adolescents Adults Human papillomavirus (HPV) Coverage
Rating:
Not applicable
2025 ∙ Cho, J. Y. Lee, H. Wannaadisai, W. Vietri, J. Chaiyakunapruk, N.
Systematic literature review of cost-effectiveness analyses of adult 15- and 20-valent pneumococcal vaccines
Adults Older adults Pneumococcal disease Economic aspects
Rating:
Not applicable
2025 ∙ Deese, J. Schaible, K. Massierer, D. Tingir, N. Fell, D. B. Atwell, J. E.
Systematic Literature Review of Maternal Antibodies in Human Milk Following Vaccination During Pregnancy or Lactation Tetanus, Pertussis, Influenza and COVID-19
Pregnant women Tetanus Pertussis Influenza COVID-19 Efficacy/effectiveness
Rating:
Critically low
2025 ∙ Zarekar, M. Al-Shehabi, H. Dorner, R. Weishaar, H. Lennemann, T. El Bcheraoui, C. Bernasconi, A.
The impact of information and communication technology on immunisation and immunisation programmes in low-income and middle-income countries: a systematic review and meta-analysis
Children Low and Middle Income Countries Coverage Logistics
Rating:
Not applicable
2025 ∙ Jacobsen, I. M. Carlander, A. L. F. Aakilde, M. von Buchwald, C.
Trends in the incidence and prevalence of juvenile-onset recurrent respiratory papillomatosis following implementation of national HPV vaccination initiatives: a systematic review
Adolescents Adults Human papillomavirus (HPV) Efficacy/effectiveness Coverage
Rating:
Critically low
2025 ∙ Bardach, A. Brizuela, M. Berrueta, M. Ciapponi, A. Sambade, J. M. Ballivian, J. Ortega, V. Castellana, N. Comande, D. Parker, E. P. K. Kampmann, B. Stegelmann, K. Xiong, X. Stergachis, A. Munoz, F. M. Buekens, P. Mazzoni, A.
Umbrella review of the safety of Chikungunya vaccine platforms used in other vaccines
Pregnant women Newborn Children Adolescents Chikungunya Safety
Rating:
Not applicable
Loading...